Inventor
Scott C. Chappel
Inventor
Milton, MA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C12NMicroorganisms or enzymes15%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
C07CAcyclic or carbocyclic compounds5%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,793,637Antibodies that bind CD39 and uses thereof202010,738,128Antibodies that bind CD39 and uses thereof202010,570,201Anti-CD47 antibodies and methods of use202010,442,858Anti-CD47 antibodies and methods of use20199,803,016'Anti-CD47 antibodies and methods of use'20177,291,339'Homogeneity and secretion of a recombinant follicle stimulating hormone (FSH) in mammalian systems'20076,663,867'Hybrid heterodimeric protein hormone comprising a TNF binding protein and a glycoprotein hormone subunit and method of using same'20036,348,444'Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans'20026,194,177'DNA encoding a hybrid heterodimeric protein'20016,193,972'Hybrid heterodimeric protein hormone'20016,096,537'Cells with multiple altered epitopes on a surface antigen for use in transplantation'20005,986,068'Site-directed mutagenesis modified glycoprotein hormones and methods of use'19995,705,479'Site-directed mutagenesis modified glycoprotein hormones and methods of use'19985,679,340'Cells with multiple altered epitopes on a surface antigen for use in transplantation'19975,674,711'Heteropolymeric protein production methods'19975,658,760'Heteropolymeric protein production methods'19975,635,475'Site-directed mutagenesis modified glycoprotein hormones and methods of use'19975,602,006'Heteropolymeric protein production methods'19975,352,779'Site-directed mutagenesis modified DNA encoding glycoprotein hormones and methods of use'19945,272,071'Method for the modification of the expression characteristics of an endogenous gene of a given cell line'19935,262,518'Ovulation kit comprising FSH isoforms with varying half-lives'19935,260,421'Site-directed mutagenesis modified glycoprotein hormones'19935,240,832'Heteropolymeric protein production methods'19935,087,615'Novel method of ovulation induction in humans'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2003Patents assigned to APPLIED RESEARCH SYSTEMS (12)· patent assignee history
1992–1999Based in Boston, MA, US· patent location history
1993–1997Patents assigned to GENZYME CORP (4)· patent assignee history
1993Based in Jamaica Plain, MA, US· patent location history
1997–2000Patents assigned to DIACRIN INC (2)· patent assignee history
1997–2020Based in Milton, MA, US· patent location history
2017–2020Patents assigned to SURFACE ONCOLOGY INC (5)· patent assignee history
2017–2020Patents assigned to ERASMUS UNIV MEDICAL CENTER (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| APPLIED RESEARCH SYSTEMS | 12 | 1992–2003 |
| SURFACE ONCOLOGY INC | 5 | 2017–2020 |
| GENZYME CORP | 4 | 1993–1997 |
| ERASMUS UNIV MEDICAL CENTER | 3 | 2017–2020 |
| DIACRIN INC | 2 | 1997–2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Milton, Massachusetts, US | 12 | 1997–2020 |
| Boston, Massachusetts, US | 11 | 1992–1999 |
| Jamaica Plain, Massachusetts, US | 1 | 1993 |